Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country

Edward Mezones-Holguin; Rocio Violeta Gamboa-Cardenas; Gadwyn Sanchez-Felix; José Chávez-Corrales; Luis Miguel Helguero-Santin; L Max Laban-Seminario; Paula Alejandra Burela-Prado; Maribel Marilu Castro-Reyes; Fabian Fiestas

Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country

Edward Mezones-Holguin, Rocio Violeta Gamboa-Cardenas, Gadwyn Sanchez-Felix, José Chávez-Corrales, Luis Miguel Helguero-Santin, L Max Laban-Seminario, Paula Alejandra Burela-Prado, Maribel Marilu Castro-Reyes, Fabian Fiestas

Resultado de la investigación: Contribución a una revista › Artículo de revisión › revisión exhaustiva

Idioma original	Inglés estadounidense
Publicación	Frontiers in Pharmacology
Volumen	10
Estado	Publicada - 8 set. 2019

Citar esto

Mezones-Holguin, E., Gamboa-Cardenas, R. V., Sanchez-Felix, G., Chávez-Corrales, J., Helguero-Santin, L. M., Laban-Seminario, L. M., Burela-Prado, P. A., Castro-Reyes, M. M., & Fiestas, F. (2019). Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country. Frontiers in Pharmacology, 10.

@article{e8ae6965e0bb4843807f91aa718eed56,

title = "Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country",

author = "Edward Mezones-Holguin and Gamboa-Cardenas, {Rocio Violeta} and Gadwyn Sanchez-Felix and Jos{\'e} Ch{\'a}vez-Corrales and Helguero-Santin, {Luis Miguel} and Laban-Seminario, {L Max} and Burela-Prado, {Paula Alejandra} and Castro-Reyes, {Maribel Marilu} and Fabian Fiestas",

year = "2019",

month = sep,

day = "8",

language = "American English",

volume = "10",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media",

}

Mezones-Holguin, E, Gamboa-Cardenas, RV, Sanchez-Felix, G, Chávez-Corrales, J, Helguero-Santin, LM, Laban-Seminario, LM, Burela-Prado, PA, Castro-Reyes, MM & Fiestas, F 2019, 'Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country', Frontiers in Pharmacology, vol. 10.

Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country. / Mezones-Holguin, Edward; Gamboa-Cardenas, Rocio Violeta; Sanchez-Felix, Gadwyn et al.

En: Frontiers in Pharmacology, Vol. 10, 08.09.2019.

Resultado de la investigación: Contribución a una revista › Artículo de revisión › revisión exhaustiva

TY - JOUR

T1 - Efficacy and safety in the continued treatment with a biosimilar drug in patients receiving Infliximab: use of a systematic review in the context of decision making from a Latin-American country

AU - Mezones-Holguin, Edward

AU - Gamboa-Cardenas, Rocio Violeta

AU - Sanchez-Felix, Gadwyn

AU - Chávez-Corrales, José

AU - Helguero-Santin, Luis Miguel

AU - Laban-Seminario, L Max

AU - Burela-Prado, Paula Alejandra

AU - Castro-Reyes, Maribel Marilu

AU - Fiestas, Fabian

PY - 2019/9/8

Y1 - 2019/9/8

M3 - Review article

SN - 1663-9812

VL - 10

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

ER -